Pharmaceutical

STAT+: With savvy bets, a dynamic duo makes Eli Lilly o...

With weight loss and Alzheimer’s data, a dynamic duo powers Eli Lilly to new hei...

Black Americans living in disadvantaged neighborhoods a...

The new study “addresses some of the environmental pressures that contribute to ...

STAT+: NIH halts funding for Colombian research facilit...

The NIH has halted funding for a pair of malaria research facilities in Colombia...

First pediatric study to test neutralizing antibodies a...

When children living with HIV are injected with neutralizing antibodies, the tre...

STAT+: Pharmalittle: Novo Nordisk spent $11 million on ...

Novo Nordisk paid for meals and travel for thousands of doctors to promote Ozemp...

The 27 best books and podcasts on health and science to...

Check out the annual STAT summer book/podcast list, with recommendations from @n...

Does the hype around generative AI reflect its technolo...

ChatGPT's release to the public in November 2022 started a wave of global intere...

Incyte’s non-segmental vitiligo treatment approved in UK

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelur...

MHRA reveals new corporate plan to expedite drug regula...

The corporate strategy aims to introduce new legislation for faster regulations,...

EC approves Vertex’s Orkambi for cystic fibrosis in chi...

The EC approved extending the label for Vertex Pharmaceuticals’ Orkambi to treat...

FSD Pharma names Zeeshan Saeed as new CEO

FSD Pharma has named Zeeshan Saeed as the new chief executive officer (CEO) of t...

OSE Immunotherapeutics’ Tedopi gains US patent for canc...

The United States Patent and Trademark Office has provided a new patent for OSE ...

NHS to provide vision-saving drug to premature babies

The UK NHS has announced plans to provide ranibizumab for preventing blindness i...

RareStone’s narcolepsy therapy receives approval in China

The Chinese NMPA has granted approval for RareStone Group’s pitolisant to treat ...

Labcorp forms spin-off of Fortrea

The spin-off will create a new global Phase I-IV CRO, patient access and technol...

Solid Dosage Packaging Solutions: Meeting the Pharmaceu...

Explore Capmatic's advanced solutions in solid dosage packaging, tailor-made for...